Zesty Paws LLC v. Nutramax Laboratories, Inc.

District Court, S.D. New York·Decided April 11, 2024·No. 1:23-cv-10849·Unknown

Opinion

ALSTON & BIRD One Atlantic Center 1201 West Peachtree Street Atlanta, GA 30309-3424 Tel: 404-881-7000 | Fax: 404-881-7777 Jason D. Rosenberg Direct Dial: 404-881-7461 Email: Jason.rosenberg@alston.com Application GRANTED. To the extent financial sales information is discussed at the preliminary injunction hearing on April 16, 2024, verbal discussions shall refrain from stating specific numbers. Any documents containing those numbers shall be displayed only to the Court, the attorneys and the witnesses at issue. Dated: April 11, 2024 New York, New York © LORNA G. SCHOFIEL: UNITED STATES DISTRICT JUDGE Re: Zesty Paws LLC v. Nutramax Laboratories, Inc. et. al (Case No. 1:23-cv-10849): Request Regarding Treatment of Financial Data at Preliminary Injunction Hearing Dear Judge Schofield: Pursuant to Section I(D)(3) of this Court’s Individual Rules and Procedures for Civil Cases, Defendant/Counterclaim Plaintiffs/Third-Party Complaint Plaintiffs Nutramax Laboratories, Inc. and Nutramax Laboratories Veterinary Sciences, Inc. (collectively, “Nutramax”), Plaintiff/Counterclaim Defendant Zesty Paws LLC (“Zesty Paws”), and Third-Party Complaint Defendant Health and Happiness (H&H) US International Incorporated (“H&H”; with Zesty Paws, the “ZP Parties”) respectfully submit this letter motion regarding the treatment of the parties’ highly confidential financial information at the April 16, 2024 preliminary injunction hearing. After discussion of this issue at the pre-hearing conference on April 5, 2024, the parties propose, to the extent reference is made to this financial information at the hearing, that those references not disclose specific numbers, and any documents containing those numbers be kept from the view of the public. I. Legal Standard Although there is a common law presumption favoring public access to court records and proceedings, that right of access is not absolute — courts have discretion to deny such public access where appropriate. Nixon v. Warner Commc’ns, Inc., 435 U.S. 589, 597-99 (1978). “Documentary Exhibits and trial testimony are also strongly presumed to be public since they are a direct part of the process of adjudication.” Encyclopedia Brown Prods., Ltd. v. Home Box Office, Inc., 26 F. Supp. 2d 606, 612 (S.D.N.Y. 1998). The issue presented here is the treatment of the parties’ financial sales information in an open court proceeding. In the Second Circuit, “There are four steps that a district court must follow in deciding a motion for closure.” United States v. Doe, 63 F.3d 121, 128 (2d Cir. 1995). These are:

1. “determine . . . if there is a substantial probability of prejudice to a compelling interest of the defendant, government, or a third party . . .”; 2. “consider whether reasonable alternatives to closure cannot adequately protect the compelling interest that would be prejudiced by public access . . .”; 3. “determine whether, under the circumstances of the case, the prejudice to the compelling interest overrides the qualified First Amendment right of access . . .”; 4. “devise a closure order that . . . is narrowly tailored to that purpose.” Id. (internal citations omitted). II. Proposal Regarding Financial Information The March 11, 2024 Declaration of W. Craig Jones and the March 15, 2024 Declaration of Pradeep Ooralath, as well as the exhibits attached to both declarations, discuss the parties’ financial sales information. These declarations were filed under seal with the Court, and the exhibits thereto were produced as HIGHLY CONFIDENTIAL INFORMATION – OUTSIDE ATTORNEYS’ EYES ONLY under the Joint Protective Order in this matter (Dkt. 80). Any testimony of Mr. Jones and Mr. Ooralath, as well as any reference to their declarations, could potentially include reference to specific numbers that the parties do not publicly disclose. However, the issues to which these numbers pertain at the Preliminary Injunction hearing do not turn on the specific numbers themselves; instead, it is these numbers’ relative positions to each other that matter. In other words, which numbers are bigger matters, but not what those numbers are. The parties’ financial sales information is the type of sensitive business information that courts routinely seal. See, e.g., United States v. Silver, No. 15-CR-93(VEC), 2016 U.S. Dist. LEXIS 51057, *15 (N.D.N.Y. Feb. 23, 2016) (“Financial records of a wholly owned business . . . and similar matters will weigh more heavily against access than conduct affecting a substantial portion of the public.”); Playtex Prods., LLC v. Muchkin, Inc., No. 14-cv-1308 (RJS), 2016 U.S. Dist. LEXIS 42261, at *40 (S.D.N.Y. Mar. 29, 2016) (holding that competitively harmful information related to “sales and revenue” should be sealed); Encyclopedia Brown, 26 F. Supp. 2d at 612-14 (finding that confidential business information should be sealed because it “provide[s] valuable insights into a company’s current business practice”). Additionally, both Nutramax and Zesty Paws1 are privately held companies, and therefore the weight given to their interest in the confidentiality of their sales and revenue figures is heightened. See, e.g., Kafati v. Kafati, No. 22- CV-9906 (VSB), 2022 U.S. Dist. LEXIS 224497, at *4 (S.D.N.Y. Dec. 9, 2022) (“Limited sealing is also appropriate for confidential business information related to a privately held Company.”); Broidy v. Global Risk Advisors LLC, No. 19-cv-11861 (MKV) (JW), 2023 U.S. Dist. LEXIS 151536, at *11 (S.D.N.Y. Aug. 24, 2023) (noting that additional weight is given to the interests of a private company seeking to protect its confidential business information from public disclosure);

Free access — add to your briefcase to read the full text and ask questions with AI

Zesty Paws LLC v. Nutramax Laboratories, Inc., (S.D.N.Y. 2024).

Zesty Paws LLC v. Nutramax Laboratories, Inc. (Zesty Paws LLC v. Nutramax Laboratories, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Nixon v. Warner Communications, Inc.
435 U.S. 589 (Supreme Court, 1978)
United States v. John Doe, James Roe
63 F.3d 121 (Second Circuit, 1995)
United States v. Amodeo
71 F.3d 1044 (Second Circuit, 1995)